Epidemiology of lower respiratory tract infections

Journal of Chemotherapy

Volumn 7, Issue 4, 1995, Pages 263-276

  Bariffi, F ^a   Sanduzzi, A ^a   Ponticiello, A ^a  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

Author keywords

Bronchitis; Pneumonia; Respiratory tract infections

Indexed keywords

ADOLESCENT; ADULT; AGED; BRONCHITIS; COMMUNICABLE DISEASE; CROSS INFECTION; FEMALE; HUMAN; MALE; MICROBIOLOGY; MIDDLE AGED; MORTALITY; PNEUMONIA; PROGNOSIS; REVIEW; RISK FACTOR; SOCIOECONOMICS; SURGICAL INFECTION; ANTIBIOTIC RESISTANCE; CONFERENCE PAPER; HOSPITALIZATION; LOWER RESPIRATORY TRACT INFECTION;

ADOLESCENT; ADULT; AGED; BRONCHITIS; COMMUNITY-ACQUIRED INFECTIONS; CROSS INFECTION; FEMALE; HUMANS; MALE; MIDDLE AGED; PNEUMONIA; PROGNOSIS; RISK FACTORS; SOCIOECONOMIC FACTORS; SURGICAL WOUND INFECTION;

AMPICILLIN; ANTIBIOTIC AGENT; METICILLIN;

EID: 0028991688     PISSN: 1120009X     EISSN: 19739478     Source Type: Journal    
DOI: 10.1179/joc.1995.7.4.263     Document Type: Article

References (79)

1. Bridge RG. The value of bacteriological studies in the age group 15-60. Dis Chest 1956; 30: 194-201.
2. Grassi C. Broncopolmoniti: diagnosi e terapia. Clin Ter 1983; 106: 381-390.
3. Kayser FH. Changes in the spectrum of organisms causing respiratory tract infections: a review. Postgrad Med J 1992; 68 (Suppl 3): S17-S23.
4. Facklam RR, Breiman RF. Current trends in bacterial respiratory pathogens. Am J Med 1991; 91 (Suppl 6A).
5. Murray CJL, Lopez AD. Global comparative assessments in the Health sector. WHO, Genova, 1994.
6. Current estimates from the National Health Interview Survey, United States 1981. Data from the National Health Survey, series 10, n. 141. Washington: U.S. Government Printing office, 1982.
7. Foy HM, Kenny GE, Cooney MK, Allan ID. Long-term epidemiology of infections with Mycoplasma pneumoniae. J Infect Dis 1979; 139: 681-687.
8. Garibaldi RA. Epidemiology of community-acquired respiratory tract infections in adults; incidence, etiology and impact. Am J Med 1985; 78 (Suppl 6B): 32-37.
9. MacFarlane J. Community-acquired pneumonia. Br J Dis Chest 1987; 81: 116-127.
10. British Thoracic Society Research Committee. Community-acquired pneumonia in adults in British Hospitals in 1982-83: a survey of aetiology, mortality, prognostic factors and ouctome. Quart J Med 1987; 62: 195-220.
11. Ortqvist A, Hedlund J, Grillner L, Jalonen E, Kallings I, Leinonen M, Kalin M. Aetiology outcome and prognostic factors in Community-acquired pneumonia requiring hospitalization. Eur Resp J 1990; 3: 1105-1113.
12. Karalaus NC, Cursons RT, leng RA, et al. Community- acquired pneumonia: etiology and prognostic index evaluation. Thorax 1991; 45: 413-418.
13. Pennington JE. Community-acquired pneumonia and acute bronchitis. Respiratory infections diagnosis and management. James E Pennington (ed). Raven Press, New York, 1983.
14. Grosman R. Can clinical symptoms predict microbial aetiology for community-acquired pneumonia? Editorial. Spirit Bull, 1993: 3.
15. ATS Guidelines for the initial management of adults with community-acquired pneumonia diagnosis, assessment of severity, and initial antimicrobial therapy. Am Rev Respir Dis 1993; 148: 1418-1426.
16. Woodhead MA, MacFarlane JJ, McCracken JS, Rose DM, Finch RG. Prospective study of the aetiology and outcome of pneumonia in the community. Lancet 1987; March 21: 671-674.
17. MacFarlane JT, Finch RG, Ward MJ, Macrae AD. Hospital study of adult community-acquired pneumonia. Lancet 1982; 31: 255-258.
18. Antela A, Guerrero A, Mesegher M, Ganzalez-Sainz J, et al. Community-acquired pneumonia: prospective study of 101 adult, immunocompetent patients for 1 year. Eur Infect Microbiol Clin 1993; 11: 525-530.
19. Reingold AL. Role of Legionellae in acute infections of the lower respiratory tract. Rev Infect Dis 1988; 10: 1018-1028.
20. Falco V, Fernandez de Sevilla T, Alegre J, Ferrer A, Martinez Vazquez JM. Legionella pneumophila—A cause of severe community-acquired pneumonia. Chest 1991; 100: 1007-1011.
21. Marrie TJ, Graystone JT, San-Wang, Cho-Chou KUO. Pneumonia associated with the TWAR strain of Chlamydia. Ann Intern Med 1987; 106: 507-511.
22. Marrie TJ. Chlamydia pneumoniae. Thorax 1993; 48: 1-4.
23. Kaye MG, Foz MJ, Bartlett JG, Braman SS, Glassroth J. The clinical spectrum of Staphylococcus aureus pulmonary infection. Chest 1990; 97: 788-792.
24. La Force FM. Community-acquired lower respiratory tract infection. Prevention and cost-control strategies. Am J Med 1985; 78 (Suppl 6B): 52-57.
25. Venkatesan P, Gladman J, MacFarlane JT, et al. A hospital study of community-acquired pneumonia in the elderly. Thorax 1990; 45: 254-258.
26. Esposito AL. Community-acquired pneumococcal pneumonia—effect of age on manifestations and outcome. Arch Intern Med 1984; 144: 945-948.
27. Garb JL, Brown RB, Garb JR, Thithill RW. Differences in etiology of pneumonias in nursing home and community patients. JAMA 1978; 240: 2169-2172.
28. Norman DC. Pneumonia in the elderly: empiric antimicrobial therapy. Geriatrics 1991; 46: 26-32.
29. Mylotte JM, Ksiazeks HC, Bentley DW. Rational approach to the antibiotic treatment of pneumoniae in the elderly. Drugs Aging 1994; 4: 21-23.
30. Sullivan RJ, Odwdle WR, Marine WM, Hierhldlzer JC. Adult pneumonia in a general hospital: etiology and host risk factors. Arch Intern Med 1972; 129: 935-942.
31. Marrie TJ, Durant H, Yates L. Community-acquired pneumonia requiring hospitalization. 5-year prospective study. Rev Infect Dis 1989; 11: 586-599.
32. Whiter J, Blainer AD, Harrison KJ, Clarke SKR. Cause of pneumonia presenting to a district general hospital. Thorax 1981; 36: 566-570.
33. Torres A, Serra-Batlles J, Ferrer A, et al. Severe community-acquired pneumonia. Epidemiology and prognostic factor. Am Rev Respir Dis 1991; 144: 312-318.
34. Pacho J, Prados MD, Capote F, Cuello KA, Garnacho J, Verano A. Severe community-acquired pneumonia. Etiology, prognosis, and treatment. Am Rev Respir Dis 1990; 142: 369-373.
35. Centers for Disease Control. Nosocomial infection surveillance, 1984. In: Surveillance summaries. 1986; 35: 17-29.
36. Ippolito G, Albertoni F, Rezza G, et al. Studio nazionale di incidenza delle infezioni nosocomiali in unita di terapia intensiva. In: Le infezioni nosocomiali in terapia (Moretti M, Ed). Oppici Edizioni Scientifiche, 81, 1985.
37. Stevens RM, Teres D, Skillman JJ. Pneumonia in an intensive care unit. Arch Intern Med 1974; 134: 106.
38. Celis R, Torres A, Gatell JM, Almela M, Rodriguez- Roisin R, August-Vidal A. Nosocomial pneumonia. Chest 1988; 2: 318-324.
39. Niederman MS, Craven DE, Fien AM, Schultz DE. Pneumonia in the critically III hospitalized patients. Chest 1990; 1: 170-181.
40. Haley RW, Hooton TM, Culver DH, Stanley RC, Emori TG. Nosocomial infections in U S Hospitals, 1975-1976: estimated frequency by selected characteristics of patients. Am J Med 1981; 70: 947-959.
41. Johanson NG. Prevention of respiratory tract infections. Am J Med 1984; 76: 69-77.
42. Craven DE, Kunches LM, Kilinsky V, Lichtenberg DA, Make BJ, McCabe WR. Risk factors for pneumonia and fatality in patients receiving continuous mechanical ventilation. Am Rev Respir Dis 1986; 133: 792-796.
43. Grassi C. In “Antibiotic Update”. Ed Intramed 1993.
44. Pennington JE. Nosocomial respiratory infection. In: “Principles and Practice of Infectious Disease” (Mandell GL, Douglas RG, Bennett JE, Eds), New York, Churchill- Livingston, 1990: 2199-2205.
45. Dilworth JP, White R, Brown EM. Oropharyngeal flora and chest infection after upper abdominal surgery. Thorax 1991; 46: 165-167.
46. La Force FM. Lower respiratory tract infections. In: “Hospital infections” (Bennett JE, Brachman PS, Eds), 3rd Edition. Boston, Little, Brown and Company, 1992: 611-639.
47. Rhame FS, Streifel AJ, Kersey JH, McGlave PB-Jr. Extrinsic risk factor for pneumonia in the patient at high risk of infection. Am J Med 1984; 76: 42-52.
48. Arnow PM, Sadigh M, Costas C, Weil D, Chudi R. Endemic and epidemic aspergillosis associated with in hospital replication of Aspergillus organisms. J Infect Dis 1991; 164: 998-1002.
49. Ortqvist A, Hammers-Berggren S, Kalin M. Respiratory tract colonization and incidence of secondary infection during hospital treatment of community-acquired pneumonia. Eur J Clin Microbiol Infect Dis 1990; 9: 725-731.
50. Cook DJ, Lane LA, Guyatt GH, Raffin TA. Nosocomial pneumonia and the role of gastric pH. Chest 1991; 100: 7-13.
51. Andrews CP, Coalson JJ, Smith JD, Johanson WG-Jr. Diagnosis of nosocomial bacterial pneumonia in acute, diffuse, lung injury. Chest 1981; 80: 254-258.
52. Barloon TJ, Galvin JR, Mori M, Stanford W, Gingrich RD. High-resolution ultrafast CT in the clinical management of febrile bone marrow transplant patient with normal or non specific chest roentgenograms. Chest 1991; 99: 128-933.
53. Edlin BR, Tokars J, Grieco MH, et al. An outbreak of multidrug-resistant tuberculosis among hospitalized patients with the acquired immunodeficiency syndrome. N Engl J Med 1992; 326: 1514-1521.
54. Gross PA, Neu HC, Van Antwerpen C, Aawapokee N. Deaths from nosocomial infections: experience in a University Hospital and a Community Hospital. Am J Med 1980; 68: 219-223.
55. Jones RC. Newer antibiotics for the surgeon. Am J Surg 1986: 152-182.
56. Stone HH. Infection in postoperative patients. Am J Med 1986; 81 (Suppl 1A): 39-44.
57. Garibaldi RA, Britt MR, Coleman ML, Reading JC, Pace NL. Risk factors for postoperative pneumonia. Am J Med 1981; 70: 677-680.
58. Fegiz G. Incidenza e costi delle infezioni chirurgiche. Giorn Ital Chemioter 1982; 29: 251-252.
59. Dilworth JP, White RJ, Brown EM. Oropharyngeal flora and chest infection after upper addominal surgery. Thorax 1991; 46: 165-167.
60. Kinnear WJ, Finch RG, Pilkington R, MacFarlane JT. Nosocomial lower respiratory tract infections in surgical wards. Thorax 1990; 45: 187-189.
61. MacFarlane JT, Colville A, Guion A, MacFarlane RM, Rosed H. Prospective study of etiology and autcome of adult lower-respiratory-tract infections in the community. Lancet 1993; 341: 511-514.
62. Garcia-Rodriguez JA, Munoz Bellido JL. Battles in bronchitis: old, new and adapting pathogens. Spirit Bull 1994; 4.
63. Hosker HSR, Jonen GM, Hawkey P. Management of community-acquired lower respiratory tract infection. Br Med J 1944; 308: 701-705.
64. Nicolotra B, Rivera M, Luman JI, Wallace RJ. Branhamella catarrhalis as a lower respiratory tract pathogen in patient with chronic lung disease. Arch Intern Med 1986; 146: 890-893.
65. Trigg CJ, Davies RJ. Antibiotic prescribing for bronchitis: time for a change? Respir Med 1994; 88: 161-163.
66. Barreiro B, Esteran L, Prats E, Veroaguer E, Dorca J, Manresa F. Branhamella catarrhalis respiratory infections. Eur Respir J 1992; 5: 675-679.
67. Pellegrino MB, Privitera A, Primavera A, Puntorieri M, Nicoletti A, Stefani S, Nicoletti G. Microbiological considerations of the egiolotical agents of lower respiratory tract infections. J Chemother 1992; 4 (4): 211-215.
68. Beam TR, Gilbert dN, Kunin CM. General guidelines for the clinical evaluation of anti-infective drug products. Clin Infect Dis 1992; Suppl 1: 5-32.
69. Grassi C. Chemioterapia antibatterica in pneumologia: stato attuale e prospettive future. L’internista 1993; 1: 10-14.
70. Klugman KP. Pneumococcal resistance to antibiotics. Clin Microbiol Rev 1990; 3: 171-196.
71. Austrian R. Pneumococcae pneumonia, diagnostic, epidemiologic, therapeutic and prophylactic considerations. Chest 1986; 90: 738-743.
72. Schito GC, Varaldo PE. Trends in the epidemiology and antibiotic resistance of clinical Staphylococcus aureusstrains in Italy. A review. J Antimicrob Chemother 1988; 21 (Suppl C): 67-78.
73. Wright PW, Wallace. Pneumonia due to Moraxella (Branhamella) catarralis. Sem Resp Infect 1989; 4: 40-46.
74. Jorgensen JM, Doern GN, Maher LA, Howell AW, Redding JS. Antimicrobial resistence among respiratory isolated of Haemophilus influenzae, Moraxella catarrhalis and Streptococcus pnuemoniae in the United States. Antimicrob Agents Chemother 1990; 34: 2075-2080.
75. Kayser FM, Morenzoni G, Santanam P. The second European Collaborative study on the frequence of antimicrobial resistance in Haemophilus influenzae. Eur J Clin Microbiol Infect Dis 1980; 9: 810-817.
76. Hassan ZA, Shaw EJ, Shooter RA, et al. Changes in antibiotic sensitivity in strains of Staphylococcus aureus 1952-1978. Br Med J 1978; 2: 536-537.
77. Gialdroni Grassi G, Bianchi L. Guidelines for the management of community-acquired pneumonia in adults. Monaldi Arch Chest Dis 1995; 50: 21-27.
78. Esposito S. In: Chemotherapy Symposium, ICC Stockholm 1993. Eur Resp Rev 1994; 4, 22.
79. Jay, In Pneumologia’90, C. Grassi et al. Pavia, Edimes, Ediz. Med. Scientifico, 1991.